CVS Pharmacy Agrees To $3.8M Settlement For ‘Maximum Strength’ Lidocaine Products
BROOKLYN, N.Y. — Three plaintiffs have asked a New York federal court to preliminarily approve a $3.8 million class settlement for claims that CVS Pharmacy Inc. misrepresented that its nonprescription lidocaine...To view the full article, register now.
Already a subscriber? Click here to view full article